Dina L. Masi - 21 May 2025 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Chief Financial Officer
Signature
/s/ Dina L Masi
Issuer symbol
INBP
Transactions as of
21 May 2025
Net transactions value
+$12,150
Form type
4
Filing time
22 May 2025, 17:41:44 UTC
Previous filing
05 Dec 2024
Next filing
10 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Masi Dina Chief Financial Officer 14 LEXINGTON WAY, LONG VALLEY /s/ Dina L Masi 22 May 2025 0001345281

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INBP Common Stock Award $12,150 +135,000 +64% $0.0900 347,200 21 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Disposed to Issuer $0 -135,000 -100% $0.000000 0 21 May 2025 Common Stock 135,000 $0.0900 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 135,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.
F2 72,500 of the options became exercisable on June 2, 2015 and the remaining 62,500 became exercisable in three equal annual installments beginning on June 2, 2016.